Phase 3 Psych Clinical Trials
27 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–20 of 27 trials
Recruiting
Phase 3
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company500 enrolled154 locationsNCT06126224
Recruiting
Phase 3
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company410 enrolled116 locationsNCT05511363
Recruiting
Phase 3
Nebulized Ketamine for the Treatment of Major Depressive Disorder
MidazolamDepressive SymptomSevere Depression+14 more
Theresa Jacob, PhD, MPH40 enrolled1 locationNCT06752759
Recruiting
Phase 3
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company800 enrolled416 locationsNCT05980949
Recruiting
Phase 3
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
Alzheimer DiseasePsychosis
Bristol-Myers Squibb325 enrolled20 locationsNCT06947941
Recruiting
Phase 3
Efficiency of a Composite Personalised Care on Functional Outcome in Early Psychosis
Psychosis
Centre Hospitalier St Anne500 enrolled13 locationsNCT05796401
Recruiting
Phase 2Phase 3
ACP-204 in Adults With Alzheimer's Disease Psychosis
Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc.1,074 enrolled145 locationsNCT06159673
Recruiting
Phase 3
Teen Driving Translation Study (NIH)
CommunicationDriveFeedback, Psychological+1 more
Ginger Yang580 enrolled1 locationNCT05696353
Recruiting
Phase 3
A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia
Cognitive ImpairmentSchizophrenia; Psychosis
European Group for Research In Schizophrenia171 enrolled16 locationsNCT07084831
Recruiting
Phase 3
Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients
Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
Tanta University40 enrolled1 locationNCT05669742
Recruiting
Phase 3
Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)
Psychological Distress
Bruyère Health Research Institute.120 enrolled7 locationsNCT07063862
Recruiting
Phase 3
Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis
Early Psychosis
University of California, San Diego120 enrolled2 locationsNCT04411225
Recruiting
Phase 2Phase 3
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
DepressionAnxietyInflammation+9 more
Cedars-Sinai Medical Center150 enrolled1 locationNCT05552053
Recruiting
Phase 3
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
AsthmaFractures, BoneAllergy+8 more
Professor Klaus Bønnelykke2,000 enrolled1 locationNCT06570889
Recruiting
Phase 3
Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
AsthmaFractures, BoneAllergy+8 more
Professor Klaus Bønnelykke2,000 enrolled1 locationNCT06560255
Recruiting
Phase 2Phase 3
Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia
InsomniaPsychiatric Disorders
Lone Baandrup255 enrolled1 locationNCT06062953
Recruiting
Phase 3
: EFFECT OF PROBIOTIC SUPPLEMENTATION ON ATYPICAL ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS ATTENDING PSYCHIATRIC CLINICS AT AINSHAMS UNIVERSITY HOSPITALS (A RANDOMIZED CONTROLLED TRIAL)
Antipsychotic Induced Weight Gain
Ain Shams University180 enrolled1 locationNCT06936137
Recruiting
Phase 3
Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
SchizophreniaApathySchizophrenia; Psychosis
Louisiana State University Health Sciences Center Shreveport80 enrolled1 locationNCT06482554
Suspended
Phase 3
A Phase III study to investigate the effect of EMD-RX5 on symptoms of psychological distress in adults with chronic pain
Psychological Distress
Emyria Ltd300 enrolled1 locationACTRN12622001319763
Not Yet Recruiting
Phase 2Phase 3
Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) effects on perception of illusions, schizotypy and cognition in healthy volunteers
Cannabis use safetySchizophreniaPsychosis
University of Western Australia36 enrolled1 locationACTRN12621000469819